NeuroPace (NPCE) Income towards Parent Company (2020 - 2026)
NeuroPace (NPCE) posted quarterly Income towards Parent Company of -$22.0 million for Q1 2026, down 235.17% year-over-year from $16.3 million in Q1 2025, and down 748.15% quarter-over-quarter from -$2.6 million in Q4 2025.
NeuroPace (NPCE) Income towards Parent Company (2020 - 2026) Analysis & Trends
NeuroPace's Income towards Parent Company history runs 7 years deep, the most recent figure standing at -$22.0 million for Q1 2026.
- In Q1 2026, Income towards Parent Company fell 235.17% year-over-year to -$22.0 million; the TTM figure through Mar 2026 stood at -$51.5 million (down 88.05% YoY), while the FY2025 annual figure was -$36.0 million, up 62.79% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$22.0 million, down from -$2.6 million in the prior quarter.
- The five-year high for Income towards Parent Company was -$2.4 million in Q4 2023, with the low at -$22.0 million in Q1 2026.
- The 5-year median for Income towards Parent Company is -$9.0 million (2024), against an average of -$9.6 million.
- The sharpest annual moves came in 2023 and 2026: Income towards Parent Company surged 78.14% in 2023, then tumbled 235.17% in 2026.
- NeuroPace's Income towards Parent Company stood at -$11.0 million in 2022, then soared by 78.14% to -$2.4 million in 2023, then tumbled by 210.94% to -$7.5 million in 2024, then soared by 65.37% to -$2.6 million in 2025, then tumbled by 748.15% to -$22.0 million in 2026.
- Business Quant data shows NPCE's Income towards Parent Company at -$22.0 million in Q1 2026, -$2.6 million in Q4 2025, and -$5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | NeuroPace | 470.13 Mn | 418.43 Mn | 18.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.97 Mn |
| Dec 31, 2025 | -2.59 Mn |
| Sep 30, 2025 | -4.99 Mn |
| Jun 30, 2025 | -21.96 Mn |
| Mar 31, 2025 | -6.55 Mn |
| Dec 31, 2024 | -7.48 Mn |
| Sep 30, 2024 | -5.69 Mn |
| Jun 30, 2024 | -7.67 Mn |
| Mar 31, 2024 | -9.02 Mn |
| Dec 31, 2023 | -2.41 Mn |
| Sep 30, 2023 | -7.37 Mn |
| Jun 30, 2023 | -9.25 Mn |
| Mar 31, 2023 | -9.56 Mn |
| Dec 31, 2022 | -11.00 Mn |
| Sep 30, 2022 | -11.68 Mn |
| Jun 30, 2022 | -12.61 Mn |
| Mar 31, 2022 | -11.46 Mn |
| Dec 31, 2021 | -10.74 Mn |
| Sep 30, 2021 | -7.93 Mn |
| Jun 30, 2021 | -6.38 Mn |